ABOS
Price
$1.42
Change
+$0.06 (+4.41%)
Updated
Aug 7 closing price
Capitalization
84.8M
4 days until earnings call
KYTX
Price
$3.32
Change
+$0.01 (+0.30%)
Updated
Aug 8, 10:42 AM (EDT)
Capitalization
143.05M
10 days until earnings call
Interact to see
Advertisement

ABOS vs KYTX

Header iconABOS vs KYTX Comparison
Open Charts ABOS vs KYTXBanner chart's image
Acumen Pharmaceuticals
Price$1.42
Change+$0.06 (+4.41%)
Volume$318.62K
Capitalization84.8M
Kyverna Therapeutics
Price$3.32
Change+$0.01 (+0.30%)
Volume$3K
Capitalization143.05M
ABOS vs KYTX Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. KYTX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and KYTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ABOS: $1.42 vs. KYTX: $3.31)
Brand notoriety: ABOS and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 60% vs. KYTX: 80%
Market capitalization -- ABOS: $84.8M vs. KYTX: $143.05M
ABOS [@Biotechnology] is valued at $84.8M. KYTX’s [@Biotechnology] market capitalization is $143.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABOS and KYTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 3 TA indicator(s) are bullish while KYTX’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 3 bullish, 5 bearish.
  • KYTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than KYTX.

Price Growth

ABOS (@Biotechnology) experienced а +1.43% price change this week, while KYTX (@Biotechnology) price change was -7.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 12, 2025.

KYTX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($143M) has a higher market cap than ABOS($84.8M). KYTX YTD gains are higher at: -11.497 vs. ABOS (-17.442). ABOS has higher annual earnings (EBITDA): -111.98M vs. KYTX (-143.14M). KYTX has more cash in the bank: 243M vs. ABOS (149M). KYTX has less debt than ABOS: KYTX (6.94M) vs ABOS (29M). ABOS (0) and KYTX (0) have equivalent revenues.
ABOSKYTXABOS / KYTX
Capitalization84.8M143M59%
EBITDA-111.98M-143.14M78%
Gain YTD-17.442-11.497152%
P/E RatioN/AN/A-
Revenue00-
Total Cash149M243M61%
Total Debt29M6.94M418%
TECHNICAL ANALYSIS
Technical Analysis
ABOSKYTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMTG0.04N/A
+2.94%
Regenerative Medical Technology Group Inc.
SFFYF25.90N/A
N/A
Signify NV
WHTAF40.01N/A
N/A
WashTec AG AUGSBURG
GLABF0.55N/A
N/A
GEMINA LABORATORIES LTD.
CMCLF1.20-0.15
-11.44%
CMOC GROUP LTD

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+4.41%
CRBU - ABOS
49%
Loosely correlated
-3.72%
BEAM - ABOS
49%
Loosely correlated
-2.40%
FHTX - ABOS
48%
Loosely correlated
+2.04%
SYRE - ABOS
48%
Loosely correlated
-4.51%
GLSI - ABOS
48%
Loosely correlated
-3.55%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IPSC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-0.60%
IPSC - KYTX
50%
Loosely correlated
-2.43%
ABOS - KYTX
47%
Loosely correlated
+4.41%
IMNM - KYTX
46%
Loosely correlated
-5.64%
HLVX - KYTX
44%
Loosely correlated
+0.49%
RXRX - KYTX
44%
Loosely correlated
-1.28%
More